CRScube is a Seoul-based eClinical company whose EDC is called cubeCDMS, alongside CTMS, eTMF and randomisation products. This page keeps to what public sources say, then turns to the questions that matter most when you shortlist it: support hours, hosting, local needs and exit.
Free sandbox · No credit card · 21 CFR Part 11 aligned
Criteria scored
5 of 8
Open with vendor
3
What to know first
The vendor
CRScube presents itself as an integrated eClinical provider for pharma companies, CROs and academic research organisations. The EDC and data management system is cubeCDMS; other modules cover trial management, trial master file and randomisation and supply. Conference and trade coverage describe a move toward combining electronic source capture, EDC and risk-based quality management in a single flow, and company news reports expansion into European studies.
Treat that as a starting point for questions. A vendor with a home market in Korea may serve a study in Seoul superbly and a study in Stockholm differently, or the other way round. The reverse applies to Capture: it serves teams worldwide from EU and US hosting, but does not claim local offices or local-language support. Whichever you pick, the generic checks in the EDC vendor audit checklist apply, and the EDC vendor comparison guide gives a scoring frame.
Cross-border questions
These are questions for any vendor and any geography. They are not statements about CRScube's own capabilities.
| Topic | Ask the vendor | Why it matters |
|---|---|---|
| Support hours | Which hours, in which languages, and what the response target is for a build issue. | A monitor in Europe and a vendor in Asia may share only a few working hours. |
| Hosting and residency | Where the production database and backups sit. | Sponsors and ethics boards often ask where participant data lives. Capture offers EU (Frankfurt) or US (N. Virginia). |
| Data protection law | How the vendor handles GDPR, or the national law that applies to your participants. | Korea has its own personal-information law and the EU has GDPR. Check with local counsel which applies to your study. |
| Regulator expectations | What documentation they supply for inspections in your region. | MFDS in Korea, EMA and national authorities in Europe and FDA in the US each set expectations. A vendor cannot give you regulatory approval of your study. |
| Languages | Which languages the interface, forms and participant tools support. | Capture makes no multilingual claim on this page; confirm what you need. |
| Contract and currency | Governing law, invoice currency, notice period. | These change the real cost and exit terms. |
| Subprocessors | Who else touches the data. | Your data protection impact assessment will ask. |
Upload a protocol to the Capture sandbox and compare the first draft with a CRScube demo on the same excerpt. Free, every feature, no credit card.
A real difference to weigh
If your operating model is built on electronic source and a central risk-based monitoring workflow, an integrated eSource, EDC and RBQM product is a serious option, and you should test the vendor's version of it. If you capture data directly in the eCRF and monitor by exception, that integration may be more than you need. The trade-offs are covered in EDC vs eSource and eSource for sites.
In Capture, site staff enter data into eCRFs, edit checks raise auto-queries at entry, and source data verification can be set per field so monitors concentrate on the critical ones. That is a lighter model. Decide first what your monitoring plan needs, then check each vendor against that plan rather than against a feature list.
Open queries
14
SDV complete
71%
Sites
5
Overdue visits
2
82% verified
68% verified
54% verified
Quote questions
Which of EDC, CTMS, TMF and randomisation are included and which are separate licences.
Who builds, who amends, and turnaround for each. See self-serve vs full-service EDC.
Per study, per participant, per site or per user, plus validation, hosting and archive lines. A request block is in the EDC quote request template.
A sample export and a demonstration of a signed record.
SDTM and Define-XML support and cost.
Full export including audit trail and any fee for leaving.
Where Capture fits
Capture lists Core at $1,000 per month including one live study plus $50 per participant per month, and Full Platform at $5,000 per month per live study plus $30 per participant per month. Study setup by the Capture team is listed at $0. Rates above 100 participants are lower but not published; ask for them in writing. Enterprise is custom.
| Line item | Basis | Qty | Unit | Total |
|---|---|---|---|---|
| Core subscription (1 live study) | months live | 10 | $1,000 | $10,000 |
| Per-participant fee | participant-months | 300 | $50 | $15,000 |
| Setup by the Capture team | one-off | 1 | $0 | $0 |
| Direct costs | $25,000 | |||
| Total | $25,000 | |||
Other regions
What Capture can and cannot offer for Korean studies.
Read more AlternativesA European cloud EDC evaluated the same way.
Read more AlternativesAnother cloud EDC with a self-serve reputation.
Read more RegionRegional notes for Nordic studies.
Read moreA Seoul-based eClinical company. Public sources name its EDC as cubeCDMS and list related CTMS, TMF and randomisation products. Confirm details with the vendor.
It depends on needs. Teams comparing cloud EDC commonly look at Viedoc, Castor and Capture. Test each on the same protocol excerpt.
No. Capture is hosted in the EU (Frankfurt) and USA (N. Virginia) and does not claim a Korean office, hosting or local-language support.
No such claim is made. Trials are approved by regulators, not software. Check with local counsel and the relevant regulator what your study needs.
Capture is used by teams worldwide, but the interface is not offered in Korean on this page. See the South Korea page and confirm language needs before you decide.
Yes. The Capture sandbox has every feature, no credit card and no time limit.
Yes. Capture is suitable for Phase 1 to 3.
Keep exploring
Free sandbox with every feature. No credit card, no sales call, and you pay only once you go live.